Gain Therapeutics appoints Jeff Riley to its Board as Independent Director

– SWITZERLAND, Lugano –  Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in CNS diseases, today announced that Jeffrey Riley joined Gain Therapeutics as Independent Board Member.…